AD essay 1 Flashcards

Discuss critically the utility of neuropsychological assessment in distinguishing AD from normal ageing. (31 cards)

1
Q

What are the main points covered in the Introduction of the source text?

A
  • Definitions of Dementia, Alzheimer’s Disease (AD), and Normal Ageing.
  • The importance of early diagnosis.
  • Thesis statement.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is Dementia defined in the source?

A

Dementia is defined as a chronic, progressive cognitive/behavioural decline that impairs daily life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Alzheimer’s Disease (AD) according to the source?

A

AD is the most common type of dementia and involves widespread cortical damage leading to cognitive/behavioural loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is Normal Ageing described in terms of cognitive changes?

A

Normal Ageing involves subtle cognitive slowing but with preserved daily function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is early diagnosis important?

A

Early diagnosis enables intervention and research.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the main argument (thesis) presented in the source?

A

The thesis is that neuropsychological assessments are key but have critical limitations and must be combined with biomarkers for maximal accuracy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the early cognitive deficits seen in AD?

A

Episodic memory encoding problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What cognitive deficits are seen in later stages of AD?

A

Later AD involves semantic memory decline, such as problems with naming and category fluency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List other cognitive/behavioural deficits mentioned as occurring in AD.

A

Other deficits include aphasia, apraxia, agnosia, visuospatial deficits, executive dysfunction, and impaired attention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does Normal Ageing compare to AD in terms of language and daily life?

A

In Normal Ageing, there is mild processing slowing, but language and daily life are preserved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What neuropathological features are associated with AD?

A

The neuropathology of AD involves Amyloid plaques and neurofibrillary tangles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which brain areas show key atrophy in AD?

A

Key atrophy occurs in the Hippocampus, posterior cingulate, and parietal cortex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the utility of screening tools like MMSE and MoCA?

A

MMSE and MoCA are screening tools that detect global cognitive decline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do MMSE scores correlate with?

A

MMSE scores correlate with Braak tau stages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give an example of a domain-specific strength of neuropsychological assessment for early AD detection.

A

Semantic fluency tests, such as naming animals, are effective for early AD detection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which type of task is sensitive to preclinical AD?

A

Visual short-term memory binding tasks are sensitive to preclinical AD.

17
Q

What is a strength of using domain-specific tasks when distinguishing AD from normal ageing?

A

Domain-specific tasks are effective at distinguishing AD versus normal ageing patterns when focused on specific domains.

18
Q

What is a limitation of neuropsychological assessment alone regarding early symptoms?

A

Early symptom overlap makes subtle changes hard to separate from age-related slowing.

19
Q

How does Cognitive Reserve present a limitation for standard neuropsychological tests in early AD?

A

Higher cognitive reserve can mask symptoms despite underlying pathology, meaning standard tests may miss early cases.

20
Q

How can high cognitive reserve influence the decline after an AD diagnosis?

A

After diagnosis, those with high reserve may decline faster.

21
Q

What challenge does the faster decline in individuals with high cognitive reserve pose?

A

This poses a challenge for interpretation of assessment results after diagnosis.

22
Q

Why are biomarkers needed in addition to cognitive testing?

A

Cognitive testing alone is often insufficient, especially early on.

23
Q

Give examples of imaging biomarkers mentioned.

A

Imaging biomarkers include MRI for hippocampal atrophy and FDG-PET for hypometabolism in posterior parietal/temporal regions.

24
Q

Give examples of fluid biomarkers from CSF mentioned.

A

CSF biomarkers include decreased Aβ42, increased Total Tau, and increased Phospho-Tau.

25
What type of fluid biomarkers are emerging?
Blood biomarkers are emerging.
26
What is the benefit of an integrated strategy combining cognitive tests and biomarkers?
Combining cognitive tests and biomarkers improves specificity for AD diagnosis.
27
Where is the integrated strategy increasingly used?
The integrated strategy is increasingly used in research settings, for example, in IWG-2 and NIA-AA criteria.
28
Summarize the role of neuropsychological assessment according to the conclusion.
Neuropsychological assessment is crucial to identify impairment patterns.
29
What limitations of neuropsychological assessment are summarized in the conclusion?
Limitations include overlap with normal ageing and cognitive reserve masking early deficits.
30
What is recommended as the best practice for precise differentiation of AD?
Multi-modal assessment, combining cognitive tests, imaging, and fluid biomarkers, is the best practice for precise differentiation.
31
What are mentioned as future directions for improving AD diagnosis?
Future directions include developing more sensitive domain-specific tasks and affordable biomarkers to achieve earlier, better diagnosis.